These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 16112122)
21. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice. Zhang S; Picard MH; Vasile E; Zhu Y; Raffai RL; Weisgraber KH; Krieger M Circulation; 2005 Jun; 111(25):3457-64. PubMed ID: 15967843 [TBL] [Abstract][Full Text] [Related]
22. Effects of simvastatin on plasma lipoproteins and hearing loss in apolipoprotein E gene-deficient mice. Cai Q; Du X; Zhou B; Cai C; Kermany MH; Zhang C; Yoo T ORL J Otorhinolaryngol Relat Spec; 2009; 71(5):244-50. PubMed ID: 19738398 [TBL] [Abstract][Full Text] [Related]
23. Effect of high-fat diet on liver and placenta fatty infiltration in early onset preeclampsia-like mouse model. Sun MN; Yang Z; Ma RQ Chin Med J (Engl); 2012 Oct; 125(19):3532-8. PubMed ID: 23044319 [TBL] [Abstract][Full Text] [Related]
24. Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification. Osako MK; Nakagami H; Shimamura M; Koriyama H; Nakagami F; Shimizu H; Miyake T; Yoshizumi M; Rakugi H; Morishita R Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1287-96. PubMed ID: 23580147 [TBL] [Abstract][Full Text] [Related]
25. The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes. Sakai N; Wada T; Matsushima K; Bucala R; Iwai M; Horiuchi M; Kaneko S J Hypertens; 2008 Apr; 26(4):780-90. PubMed ID: 18327089 [TBL] [Abstract][Full Text] [Related]
26. Modulation of plasma lipid levels affects benzo[a]pyrene-induced DNA damage in tissues of two hyperlipidemic mouse models. Curfs DM; Beckers L; Godschalk RW; Gijbels MJ; van Schooten FJ Environ Mol Mutagen; 2003; 42(4):243-9. PubMed ID: 14673869 [TBL] [Abstract][Full Text] [Related]
28. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis. Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031 [TBL] [Abstract][Full Text] [Related]
29. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. van den Born BJ; Koopmans RP; van Montfrans GA Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041 [TBL] [Abstract][Full Text] [Related]
30. Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen. Bohlender J; Bader M; Ménard J; Nussberger J J Hypertens; 2012 Aug; 30(8):1597-605. PubMed ID: 22728903 [TBL] [Abstract][Full Text] [Related]
31. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr. Lloyd DJ; McCormick J; Helmering J; Kim KW; Wang M; Fordstrom P; Kaufman SA; Lindberg RA; Véniant MM Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E496-505. PubMed ID: 18160459 [TBL] [Abstract][Full Text] [Related]
32. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys. Chandramohan G; Bai Y; Norris K; Rodriguez-Iturbe B; Vaziri ND Am J Nephrol; 2008; 28(1):158-67. PubMed ID: 17951998 [TBL] [Abstract][Full Text] [Related]
33. Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule. Lavoie JL; Lake-Bruse KD; Sigmund CD Am J Physiol Renal Physiol; 2004 May; 286(5):F965-71. PubMed ID: 15075192 [TBL] [Abstract][Full Text] [Related]
34. Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats. Kuczera M; Hilgers KF; Lisson C; Ganten D; Hilgenfeldt U; Ritz E; Mann JF J Hypertens; 1991 Jan; 9(1):41-8. PubMed ID: 1848258 [TBL] [Abstract][Full Text] [Related]
35. New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions. Vaughan EF; Laragh JH Urol Clin North Am; 1975 Jun; 2(2):237-57. PubMed ID: 1098253 [TBL] [Abstract][Full Text] [Related]
36. Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation. Candido R; Carraro M; Fior F; Artero ML; Zennaro C; Burrell LM; Davis BJ; Cattin MR; Bardelli M; Faccini L; Carretta R; Fabris B Am J Hypertens; 2005 Jun; 18(6):844-50. PubMed ID: 15925746 [TBL] [Abstract][Full Text] [Related]